PMC:7216762 / 7230-7785
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T6 | 26-34 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T7 | 205-213 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
| T8 | 264-273 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
| T9 | 298-311 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T6 | 298-311 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T20 | 58-78 | Disease | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/MONDO_0008383 |
| T21 | 69-78 | Disease | denotes | arthritis | http://purl.obolibrary.org/obo/MONDO_0005578 |
| T22 | 109-117 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T37 | 13-14 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T38 | 298-311 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T39 | 392-393 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 166-168 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T12 | 508-512 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 58-78 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T2 | 205-220 | Phenotype | denotes | cytokine storms | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T49 | 0-137 | Sentence | denotes | Tocilizumab, a monoclonal antibody developed for treating rheumatoid arthritis, was first used to treat some COVID-19 patients in Naples. |
| T50 | 138-343 | Sentence | denotes | It inhibits the receptor of IL-6, likely damping the effect of the cytokine storms (i.e., massive release of pro-inflammatory cytokines that overstimulates the immune system) observed in more severe cases. |
| T51 | 344-555 | Sentence | denotes | Today, AIFA swiftly authorized the beginning of a clinical trial,6 involving many hospitals in Italy, that was made possible also by Roche committing to supply the drug for free for the whole emergency duration. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 71 | 166-170 | Gene | denotes | IL-6 | Gene:3569 |
| 72 | 118-126 | Species | denotes | patients | Tax:9606 |
| 73 | 0-11 | Chemical | denotes | Tocilizumab | MESH:C502936 |
| 74 | 58-78 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 75 | 109-117 | Disease | denotes | COVID-19 | MESH:C000657245 |